These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22795392)

  • 1. Yawning as a dose-dependent side effect of treatment with escitalopram.
    Roncero C; Mezzatesta-Gava M; Grau-López L; Daigre C
    Neurologia; 2013; 28(9):589-90. PubMed ID: 22795392
    [No Abstract]   [Full Text] [Related]  

  • 2. Attention to side effects enhances medical adherence.
    Vinberg M
    Acta Psychiatr Scand; 2007 Jan; 115(1):82. PubMed ID: 17201871
    [No Abstract]   [Full Text] [Related]  

  • 3. Do your patients suffer from excessive yawning?
    Gutiérrez-Alvarez AM
    Acta Psychiatr Scand; 2007 Jan; 115(1):80-1. PubMed ID: 17201870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of electric shock-like sensations on escitalopram discontinuation.
    Prakash O; Dhar V
    J Clin Psychopharmacol; 2008 Jun; 28(3):359-60. PubMed ID: 18480703
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
    Mundo E; Bianchi L; Bellodi L
    J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram-associated serotonin toxicity.
    Vari G; Beckson M
    J Clin Psychopharmacol; 2007 Apr; 27(2):229-30. PubMed ID: 17414259
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual and auditory hallucinations associated with citalopram treatment.
    Waltereit R; Eifler S; Schirmbeck F; Zink M
    J Clin Psychopharmacol; 2013 Aug; 33(4):583-4. PubMed ID: 23775056
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose escitalopram treatment in patients with obsessive-compulsive disorder: a naturalistic case series.
    Shim GS; Kang DH; Kwon JS
    J Clin Psychopharmacol; 2008 Feb; 28(1):108-10. PubMed ID: 18204356
    [No Abstract]   [Full Text] [Related]  

  • 9. Escitalopram in the treatment of obsessive-compulsive disorder.
    Zohar J
    Expert Rev Neurother; 2008 Mar; 8(3):339-49. PubMed ID: 18345966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escitalopram.
    Aronson S; Delgado P
    Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations on safety concerns about citalopram prescribing.
    Sheeler RD; Ackerman MJ; Richelson E; Nelson TK; Staab JP; Tangalos EG; Dieser LM; Cunningham JL
    Mayo Clin Proc; 2012 Nov; 87(11):1042-5. PubMed ID: 23018033
    [No Abstract]   [Full Text] [Related]  

  • 12. Citalopram in refractory obsessive-compulsive disorder: an open study.
    Marazziti D; Dell'Osso L; Gemignani A; Ciapparelli A; Presta S; Nasso ED; Pfanner C; Cassano GB
    Int Clin Psychopharmacol; 2001 Jul; 16(4):215-9. PubMed ID: 11459335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoid tumor, selective serotonin reuptake inhibitors, and diarrhea.
    Simbera Z; Balon R
    Psychosomatics; 2005; 46(1):88-9. PubMed ID: 15765829
    [No Abstract]   [Full Text] [Related]  

  • 14. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
    Koponen H; Lepola U; Leinonen E; Jokinen R; Penttinen J; Turtonen J
    Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Citalopram].
    El-Armouche A; Zolk O; Eschenhagen T
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2253-6. PubMed ID: 14574639
    [No Abstract]   [Full Text] [Related]  

  • 16. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
    Lepola UM; Loft H; Reines EH
    Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract]   [Full Text] [Related]  

  • 18. [SSRI-induced akathesia].
    Hofmann M; Vidoni F
    Psychiatr Prax; 1996 May; 23(3):143-4. PubMed ID: 8711007
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical efficacy of citalopram in patients with obsessive-compulsive disorder].
    Jakitowicz J; Nowicki Z; Wiśniewski G
    Psychiatr Pol; 2002; 36(6 Suppl):297-301. PubMed ID: 12647452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy.
    Stein DJ; Carey PD; Lochner C; Seedat S; Fineberg N; Andersen EW
    CNS Spectr; 2008 Jun; 13(6):492-8. PubMed ID: 18567973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.